Serpin peptidase inhibitor clade A member 1 is a biomarker of poor prognosis in gastric cancer
Main Authors: | Kwon, C H, Park, H J, Lee, J R, Kim, H K, Jeon, T Y, Jo, H-J, Kim, D H, Kim, G H, Park, D Y |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229634/ |
Similar Items
-
c-Myc expression is related with cell proliferation and associated with poor clinical outcome in human gastric cancer.
by: Han, S., et al.
Published: (1999) -
Serpin peptidase inhibitor (SERPINB5) haplotypes are associated with susceptibility to hepatocellular carcinoma
by: Yang, Shun-Fa, et al.
Published: (2016) -
Serum biomarker panels for the diagnosis of gastric adenocarcinoma
by: Ahn, H S, et al.
Published: (2012) -
Snail and serpinA1 promote tumor progression and predict prognosis in colorectal cancer
by: Kwon, Chae Hwa, et al.
Published: (2015) -
Gastric lymphangioma.
by: Kim, H. S., et al.
Published: (2001)